• Citer

Prospective, randomized, double-blind, double-dummy, active-controlled, phase 3 clinical trial comparing the safety and efficacy of intranasal dexmedetomidine to oral midazolam as premedication for propofol sedation in pediatric patients undergoing magnetic resonance imaging: the MIDEX MRI trial.

par Wabelo, Olivia Nzungu;Schmartz, Denis ;Giancursio, Mario;De Pooter, Françoise;Caruso, Giulia ;Fils, Jean-François;Van der Linden, Philippe
Référence Trials, 24, 1, page (518)
Publication Publié, 2023-08-01

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Prospective, randomized, double-blind, double-dummy, active-controlled, phase 3 clinical trial comparing the safety and efficacy of intranasal dexmedetomidine to oral midazolam as premedication for propofol sedation in pediatric patients undergoing magnetic resonance imaging: the MIDEX MRI trial.
Auteur:	Wabelo, Olivia Nzungu; Schmartz, Denis; Giancursio, Mario; De Pooter, Françoise; Caruso, Giulia; Fils, Jean-François; Van der Linden, Philippe
Informations sur la publication:	Trials, 24, 1, page (518)
Statut de publication:	Publié, 2023-08-01
Sujet CREF:	Sciences bio-médicales et agricoles
Mots-clés:	Dexmedetomidine
	MRI
	Midazolam
	Pediatric sedation
MeSH keywords:	Child
	Humans
	Child, Preschool
	Midazolam -- adverse effects
	Propofol
	Dexmedetomidine
	Hypnotics and Sedatives -- adverse effects
	Prospective Studies
	Premedication -- methods
	Magnetic Resonance Spectroscopy
	Magnetic Resonance Imaging
	Anesthesia
	Administration, Intranasal
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:1745-6215
	info:doi/10.1186/s13063-023-07529-0
	info:pii/10.1186/s13063-023-07529-0
	info:scp/85167772467
	info:pmid/37568242
	PMC10422697